Literature DB >> 16432526

The Dimensional Yale-Brown Obsessive-Compulsive Scale (DY-BOCS): an instrument for assessing obsessive-compulsive symptom dimensions.

M C Rosario-Campos1, E C Miguel, S Quatrano, P Chacon, Y Ferrao, D Findley, L Katsovich, L Scahill, R A King, S R Woody, D Tolin, E Hollander, Y Kano, J F Leckman.   

Abstract

Obsessive-compulsive disorder (OCD) encompasses a broad range of symptoms representing multiple domains. This complex phenotype can be summarized using a few consistent and temporally stable symptom dimensions. The objective of this study was to assess the psychometric properties of the Dimensional Yale-Brown Obsessive-Compulsive Scale (DY-BOCS). This scale measures the presence and severity of obsessive-compulsive (OC) symptoms within six distinct dimensions that combine thematically related obsessions and compulsions. The DY-BOCS includes portions to be used as a self-report instrument and portions to be used by expert raters, including global ratings of OC symptom severity and overall impairment. We assessed 137 patients with a Diagnostic and Statistical Manual-IV diagnosis of OCD, aged 6-69 years, from sites in the USA, Canada and Brazil. Estimates of the reliability and validity of both the expert and self-report versions of the DY-BOCS were calculated and stratified according to age (pediatric vs. adult subjects). The internal consistency of each of the six symptom dimensions and the global severity score were excellent. The inter-rater agreement was also excellent for all component scores. Self-report and expert ratings were highly intercorrelated. The global DY-BOCS score was highly correlated with the total Yale-Brown Obsessive-Compulsive Scale score (Pearson r = 0.82, P<0.0001). Severity scores for individual symptom dimensions were largely independent of one another, only modestly correlated with the global ratings, and were also differentially related to ratings of depression, anxiety and tic severity. No major differences were observed when the results were stratified by age. These results indicate that the DY-BOCS is a reliable and valid instrument for assessing multiple aspects of OCD symptom severity in natural history, neuroimaging, treatment response and genetic studies when administered by expert clinicians or their highly trained staff.

Entities:  

Mesh:

Year:  2006        PMID: 16432526     DOI: 10.1038/sj.mp.4001798

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  80 in total

Review 1.  A 2012 evidence-based algorithm for the pharmacotherapy for obsessive-compulsive disorder.

Authors:  Dan J Stein; Nastassja Koen; Naomi Fineberg; Leonardo F Fontenelle; Hisato Matsunaga; David Osser; H Blair Simpson
Journal:  Curr Psychiatry Rep       Date:  2012-06       Impact factor: 5.285

2.  Functional neural mechanisms of sensory phenomena in obsessive-compulsive disorder.

Authors:  Carina Brown; Rebbia Shahab; Katherine Collins; Lazar Fleysher; Wayne K Goodman; Katherine E Burdick; Emily R Stern
Journal:  J Psychiatr Res       Date:  2018-11-21       Impact factor: 4.791

3.  Development of a patient adherence scale for exposure and response prevention therapy.

Authors:  Helen Blair Simpson; Michael Maher; Jessica R Page; Carly J Gibbons; Martin E Franklin; Edna B Foa
Journal:  Behav Ther       Date:  2009-05-29

4.  Development and validation of the Youth Obsessive-Compulsive Symptoms Scale (YOCSS).

Authors:  Elien De Caluwé; Barbara De Clercq
Journal:  Child Psychiatry Hum Dev       Date:  2014-12

5.  Broad autism spectrum and obsessive-compulsive symptoms in adults with the fragile X premutation.

Authors:  A Schneider; C Johnston; F Tassone; S Sansone; R J Hagerman; E Ferrer; S M Rivera; D Hessl
Journal:  Clin Neuropsychol       Date:  2016-06-29       Impact factor: 3.535

Review 6.  Autism spectrum and obsessive-compulsive disorders: OC behaviors, phenotypes and genetics.

Authors:  Suma Jacob; Angeli Landeros-Weisenberger; James F Leckman
Journal:  Autism Res       Date:  2009-12       Impact factor: 5.216

7.  Risk factors for obsessive-compulsive symptoms. Follow-up of a community-based youth cohort.

Authors:  Pedro Macul Ferreira de Barros; Maria Conceição do Rosário; Natalia Szejko; Natália Polga; Guaraci de Lima Requena; Beatriz Ravagnani; Daniel Fatori; Marcelo Camargo Batistuzzo; Marcelo Queiroz Hoexter; Luis Augusto Rohde; Guilherme Vanoni Polanczyk; James Frederick Leckman; Eurípedes Constantino Miguel; Pedro Gomes de Alvarenga
Journal:  Eur Child Adolesc Psychiatry       Date:  2020-02-19       Impact factor: 4.785

8.  Comparing OCD-affected youth with and without religious symptoms: Clinical profiles and treatment response.

Authors:  Monica S Wu; Michelle Rozenman; Tara S Peris; Joseph O'Neill; R Lindsey Bergman; Susanna Chang; John Piacentini
Journal:  Compr Psychiatry       Date:  2018-07-25       Impact factor: 3.735

Review 9.  Obsessive-compulsive disorder.

Authors:  Dan J Stein; Daniel L C Costa; Christine Lochner; Euripedes C Miguel; Y C Janardhan Reddy; Roseli G Shavitt; Odile A van den Heuvel; H Blair Simpson
Journal:  Nat Rev Dis Primers       Date:  2019-08-01       Impact factor: 52.329

Review 10.  Recent advances in research on cognition and emotion in OCD: a review.

Authors:  Amanda W Calkins; Noah C Berman; Sabine Wilhelm
Journal:  Curr Psychiatry Rep       Date:  2013-05       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.